These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8146565)
1. [Progestin treatments of menopause]. Gompel A Rev Prat; 1993 Dec; 43(20):2645-50. PubMed ID: 8146565 [TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
3. The rationale for a wider range of progestogens. Skouby SO Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382 [TBL] [Abstract][Full Text] [Related]
4. Current trends in hormone replacement therapy. Khashoggi TY Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567 [TBL] [Abstract][Full Text] [Related]
5. Progestogen use in women approaching the menopause and breast cancer risk. Campagnoli C; Ambroggio S; Lotano MR; Peris C Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958 [TBL] [Abstract][Full Text] [Related]
6. Effects of sex steroids on proliferation in normal mammary tissue. Söderqvist G Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352 [TBL] [Abstract][Full Text] [Related]
8. [Progesterone, progestagens in premenstrual syndrome, the perimenopause and the menopause]. Salvat J; Jolles C Praxis (Bern 1994); 1995 Jan; 84(3):70-5. PubMed ID: 7846431 [TBL] [Abstract][Full Text] [Related]
9. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort. Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857 [TBL] [Abstract][Full Text] [Related]
10. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909 [TBL] [Abstract][Full Text] [Related]
12. Tibolone: new preparation. Menopausal symptoms: oestrogen-progestogen combinations are still the reference treatment. Prescrire Int; 2002 Jun; 11(59):79-82. PubMed ID: 12068842 [TBL] [Abstract][Full Text] [Related]
13. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women. Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624 [TBL] [Abstract][Full Text] [Related]
14. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
15. [Cancer risk of hormone replacement treatment in the menopause]. Pejovic-Lenfant MH J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):153-66. PubMed ID: 2656835 [TBL] [Abstract][Full Text] [Related]
18. The lack of effect of progestogen on bone. Lindsay R J Reprod Med; 1999 Feb; 44(2 Suppl):215-20. PubMed ID: 11392035 [TBL] [Abstract][Full Text] [Related]
19. Progestogens in the treatment of secondary amenorrhea. Simon JA J Reprod Med; 1999 Feb; 44(2 Suppl):185-90. PubMed ID: 11392030 [TBL] [Abstract][Full Text] [Related]